Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma
4 Vues
• 07/18/23
0
0
Intégrer
administrator
Les abonnés
Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires